Evidence map›Paper›PMID 17703529›Full record

ArticleThe New England journal of medicine2007

Yearly zoledronic acid in postmenopausal osteoporosis.

Roger Karam, John Camm, Michael McClung

Abstract readLetterComment
PubMed
In one paragraph

Article in The New England journal of medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Association between bisphosphonate use and stroke risk: a meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Pooled it
  2. Pooled it
  3. Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
    Article
  12. Review
  13. Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
    Article
  14. Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2012
    Article
  15. Article
  16. Review
  17. Review
  18. Oral bisphosphonates and risk of ischemic stroke: a case-control study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Article
  19. Review
  20. Atrial fibrillation and the use of oral bisphosphonates.Therapeutics and clinical risk management · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Roger Karam
John Camm
Michael McClung

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAgedAlendronateAtrial FibrillationBone Density Conservation AgentsDiphosphonatesEtidronic AcidFemaleFractures, BoneHumansImidazolesOsteoporosis, PostmenopausalRisedronic AcidZoledronic AcidAlendronateBone Density Conservation AgentsDiphosphonatesEtidronic AcidImidazolesRisedronic AcidZoledronic Acid

Identifiers

PMID17703529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.